A61K 39/07
Bacillus
A61K39/07 (Bacillus) appears on 207 US grants and 364 published applications in this corpus.
Search patents in A61K- Granted patents
- 207
- Published applications
- 364
- Assignees
- 197
- Inventors
- 627
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 5 |
| 2003 | 1 | 6 |
| 2004 | 0 | 8 |
| 2005 | 2 | 11 |
| 2006 | 3 | 10 |
| 2007 | 1 | 11 |
| 2008 | 4 | 15 |
| 2009 | 4 | 10 |
| 2010 | 12 | 20 |
| 2011 | 5 | 24 |
| 2012 | 10 | 21 |
| 2013 | 10 | 14 |
| 2014 | 15 | 22 |
| 2015 | 13 | 22 |
| 2016 | 14 | 24 |
| 2017 | 20 | 24 |
| 2018 | 15 | 25 |
| 2019 | 20 | 13 |
| 2020 | 13 | 13 |
| 2021 | 18 | 17 |
| 2022 | 8 | 11 |
| 2023 | 6 | 9 |
| 2024 | 3 | 13 |
| 2025 | 1 | 14 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- In-vitro transcript MRNA and pharmaceutical composition comprising same24 Mar 2026US 12,582,707 B2
- Targeting moDC to enhance vaccine efficacy on mucosal surface10 Mar 2026US 12,569,557 B2University of Florida Research Foundation, Inc.
- BCG car constructs and methods of their manufacture and use13 Jan 2026US 12,522,651 B2Versiti Blood Research Institute Foundation, Inc.
- Bacillus subtilis JCK-1398 strain inducing resistance in various plants, and composition and method for controlling pine wilt disease by using same16 Dec 2025US 12,495,801 B2Jan153 Biotech Inc.
- Compositions comprising recombinant Bacillus cells and an insecticide25 Jun 2024US 12,016,912 B2Bayer CropScience AG
- Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions16 Apr 2026US 2026/0102478 A1Longhorn Vaccines and Diagnostics, LLC
- Targeting modc to enhance vaccine efficacy on mucosal surface12 Mar 2026US 2026/0069685 A1
- Treatment and prevention of viral infections25 Sep 2025US 2025/0295748 A1Sporegen Limited
- Thermostable particle-based compositions and manufacturing process4 Sep 2025US 2025/0275922 A1Iowa State University Research Foundation, Inc.
- Visco-elastic Solid Formulation for Oral Delivery of a Biologically Active Agent4 Sep 2025US 2025/0276055 A1US Biologic, Inc.
Most cited
By later US patents
- Compositions for treatment or prevention of bioterrorism56US 6,991,779 B2MannKind Corporation · 2006
- Transcutaneous delivery of therapeutic agents49US 8,728,491 B2Alba Therapeutics Corporation · 2014
- Immunization and/or treatment of parasites and infectious agents by live bacteria41US 8,771,669 B12014
- Bacillus based delivery system and methods of use36US 9,132,175 B2The Curators of the University of Missouri · 2015
- Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots35US 9,573,980 B2Spogen Biotech Inc. · 2017